Saltigo increases prices for 1,2,4 Triazol

Langenfeld – Global custom synthesis specialist Saltigo GmbH will be raising its prices for the product group 1,2,4 Triazol (CAS 00288-88-0) by 10 % effective September 1, 2010. The reasons for the measure are substantial increases in raw materials and energy costs.

Saltigo is one of the leader in the production and marketing of 1,2,4 Triazol. The intermediate is used, among other things, in the chemical synthesis of active agricultural and pharmaceutical ingredients.

Saltigo GmbH is a leading supplier in the field of custom synthesis. The company of specialty chemicals group LANXESS belongs to the Advanced Intermediates segment, which achieved total sales in 2009 of EUR 1,104 million. Saltigo, headquartered in Langenfeld and with production facilities in Leverkusen and Dormagen, employs around 1,400 staff worldwide. LANXESS Corporation operates a site for Saltigo in Redmond (Washington, United States).

Leverkusen, August 25, 2010
erb-bol (2010-00131e)

Forward-looking statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by LANXESS AG management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Information for editors:
All Saltigo news releases and their accompanying photos can be found at http://press.lanxess.com. 

Detailed information about the company can be found on the internet at http://www.saltigo.com. You can find information concerning LANXESS chemistry in our WebMagazine at http://webmagazine.lanxess.com.